The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Chemistry and Biology Of Multicomponent Reactions
Open accessAbstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTChemistry and Biology Of Multicomponent ReactionsAlexander Dömling*†‡, Wei Wang†§, and Kan Wang†View Author Information† Department of Pharmaceutical Sciences, University of Pittsburgh, Biomedical Science Tower 3, Suite 10019, 3501 Fifth Avenue, Pittsburgh, Pennsylvania 15261, United States‡ Chair of Drug Design, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands§ Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, P. R. China*E-mail: [email protected]. Fax: (+)412-383-5298.Cite this: Chem. Rev. 2012, 112, 6, 3083–3135Publication Date (Web):March 22, 2012Publication History Received23 July 2010Published online22 March 2012Published inissue 13 June 2012https://pubs.acs.org/doi/10.1021/cr100233rhttps://doi.org/10.1021/cr100233rreview-articleACS PublicationsCopyright © 2012 American Chemical SocietyRequest reuse permissionsArticle Views31588Altmetric-Citations1987LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Inhibitors,Peptides and proteins,Reaction products,Receptors,Scaffolds Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Recent Developments in Isocyanide Based Multicomponent Reactions in Applied Chemistry
Dömling, A. (2006) · Chemical Reviews · doi:10.1021/cr0505728 · Cited by 4,106
Self-citationMulticomponent Reactions with Isocyanides
Dömling, A., & Ugi, I. (2000) · Angewandte Chemie · doi:10.1002/1521-3773(20000915)39:18<3168::aid-anie3168>3.0.co;2-u · Cited by 4,077
Self-citationDomino Reactions in Organic Synthesis
Tietze, L. F. (1996) · Chemical Reviews · doi:10.1021/cr950027e · Cited by 3,923
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Domino Reactions in Organic Synthesis
Tietze, L. F., Brasche, G., & Gericke, K. M. (2006) · Wiley eBooks · doi:10.1002/9783527609925 · Cited by 2,222
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Steinmann, P., Keiser, J., Bos, R., Tanner, M., & Utzinger, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70521-7 · Cited by 2,156
Crystal structure of the human β2 adrenergic G-protein-coupled receptor
Rasmussen, S. G. F., Choi, H.-J., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S., Edwards, P. C., Burghammer, M., Ratnala, V. R. P., Sanishvili, R., Fischetti, R. F., et al. (2007) · Nature · doi:10.1038/nature06325 · Cited by 1,930
Einfluss der Configuration auf die Wirkung der Enzyme
Fischer, E. (1894) · Berichte der deutschen chemischen Gesellschaft · doi:10.1002/cber.18940270364 · Cited by 1,835
Serine Protease Mechanism and Specificity
Hedstrom, L. (2002) · Chemical Reviews · doi:10.1021/cr000033x · Cited by 1,827
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,781
Natural Product Synthesis Using Multicomponent Reaction Strategies
Touré, B. B., & Hall, D. G. (2009) · Chemical Reviews · doi:10.1021/cr800296p · Cited by 1,705
Targeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
100 years of the biginelli dihydropyrimidine synthesis
Oliver Kappe, C. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)87971-0 · Cited by 1,228
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2806 · Cited by 1,226
Molecular imaging in drug development
Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., & Gambhir, S. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2290 · Cited by 1,171
Multiple-Component Condensation Strategies for Combinatorial Library Synthesis
Armstrong, R. W., Combs, A. P., Tempest, P. A., Brown, S. D., & Keating, T. A. (1996) · Accounts of Chemical Research · doi:10.1021/ar9502083 · Cited by 1,111
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
“Multi-component Reactions : Emerging Chemistry in Drug Discovery” ‘From Xylocain to Crixivan’
Hulme, C., & Gore, V. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033368600 · Cited by 1,035
Recent Developments in the Isonitrile‐Based Multicomponent Synthesis of Heterocycles
Zhu, J. (2003) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200390167 · Cited by 956
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Eckelman, B. P., Salvesen, G. S., & Scott, F. L. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400795 · Cited by 813
The rise of fragment-based drug discovery
Murray, C. W., & Rees, D. C. (2009) · Nature Chemistry · doi:10.1038/nchem.217 · Cited by 791
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J., Peck, W. L., et al. (2005) · Pain · doi:10.1016/j.pain.2005.01.002 · Cited by 789
Cysteine Proteases and Their Inhibitors
Otto, H.-H., & Schirmeister, T. (1997) · Chemical Reviews · doi:10.1021/cr950025u · Cited by 759
Crystal structure of the ATP-gated P2X4 ion channel in the closed state
Kawate, T., Michel, J. C., Birdsong, W. T., & Gouaux, E. (2009) · Nature · doi:10.1038/nature08198 · Cited by 738
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Kazantsev, A. G., & Thompson, L. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2681 · Cited by 711
Catalytic triads and their relatives
Dodson, G. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01254-7 · Cited by 655
Kinetic and Catalytic Mechanisms of Protein Kinases
Adams, J. A. (2001) · Chemical Reviews · doi:10.1021/cr000230w · Cited by 627
Multicomponent reactions in organic chemistry
Ugi, I., Dömling, A. S. S., & Hörl, W. (1994) · Endeavour · doi:10.1016/s0160-9327(05)80086-9 · Cited by 597
Self-citationPromotion of sleep by targeting the orexin system in rats, dogs and humans
Brisbare-Roch, C., Dingemanse, J., Koberstein, R., Hoever, P., Aissaoui, H., Flores, S., Mueller, C., Nayler, O., van Gerven, J., de Haas, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1544 · Cited by 573
MDM2 inhibitors for cancer therapy
Vassilev, L. T. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.002 · Cited by 532
IAP-targeted therapies for cancer
LaCasse, E. C., Mahoney, D. J., Cheung, H. H., Plenchette, S., Baird, S., & Korneluk, R. G. (2008) · Oncogene · doi:10.1038/onc.2008.302 · Cited by 524
Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids
Deres, K., Schröder, C. H., Paessens, A., Goldmann, S., Hacker, H. J., Weber, O., Krämer, T., Niewöhner, U., Pleiss, U., Stoltefuss, J., et al. (2003) · Science · doi:10.1126/science.1077215 · Cited by 508
Structure-based design of aliskiren, a novel orally effective renin inhibitor
Wood, J. M., Maibaum, J., Rahuel, J., Grütter, M. G., Cohen, N.-C., Rasetti, V., Rüger, H., Göschke, R., Stutz, S., Fuhrer, W., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01451-7 · Cited by 506
Condensationsprodukte aus Aldehydammoniak und ketonartigen Verbindungen
Hantzsch, A. (1881) · Berichte der deutschen chemischen Gesellschaft · doi:10.1002/cber.18810140214 · Cited by 496
Chloride channels as drug targets
Verkman, A. S., & Galietta, L. J. V. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2780 · Cited by 469
Recent advances in isocyanide-based multicomponent chemistry
Dömling, A. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00328-9 · Cited by 462
Self-citationBencivenni, G., Wu, L., Mazzanti, A., Giannichi, B., Pesciaioli, F., Song, M., Bartoli, G., & Melchiorre, P. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200903192 · Cited by 448
A New and Practical Synthesis of α-Amino Acids from Alkenyl Boronic Acids
Petasis, N. A., & Zavialov, I. A. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963178n · Cited by 444
The Chemistry of Isocyanides, their MultiComponent Reactions and their Libraries
Ugi, I., Werner, B., & Dömling, A. (2003) · Molecules · doi:10.3390/80100053 · Cited by 444
Self-citationDrugs targeting the renin–angiotensin–aldosterone system
Zaman, M. A., Oparil, S., & Calhoun, D. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd873 · Cited by 439
Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells
Grasberger, B. L., Lu, T., Schubert, C., Parks, D. J., Carver, T. E., Koblish, H. K., Cummings, M. D., LaFrance, L. V., Milkiewicz, K. L., Calvo, R. R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049137g · Cited by 432
Bencivenni, G., Wu, L., Mazzanti, A., Giannichi, B., Pesciaioli, F., Song, M., Bartoli, G., & Melchiorre, P. (2009) · Angewandte Chemie · doi:10.1002/ange.200903192 · Cited by 427
Structural basis of inhibitor selectivity in MAP kinases
Wang, Z., Canagarajah, B. J., Boehm, J. C., Kassisà, S., Cobb, M. H., Young, P. R., Abdel-Meguid, S., Adams, J. L., & Goldsmith, E. J. (1998) · Structure · doi:10.1016/s0969-2126(98)00113-0 · Cited by 423
Conformational thermostabilization of the β1-adrenergic receptor in a detergent-resistant form
Serrano-Vega, M. J., Magnani, F., Shibata, Y., & Tate, C. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711253105 · Cited by 422
Structure and Mechanism of the Pepsin-Like Family of Aspartic Peptidases
Dunn, B. M. (2002) · Chemical Reviews · doi:10.1021/cr010167q · Cited by 372
Triphosgene, a Crystalline Phosgene Substitute
Eckert, H., & Forster, B. (1987) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198708941 · Cited by 369
Rosenblum, S. B., Huynh, T., Afonso, A., Davis, H. R., Yumibe, N., Clader, J. W., & Burnett, D. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970701f · Cited by 361
The 7 TM G‐Protein‐Coupled Receptor Target Family
Jacoby, E., Bouhelal, R., Gerspacher, M., & Seuwen, K. (2006) · ChemMedChem · doi:10.1002/cmdc.200600134 · Cited by 359
Unlocking the molecular secrets of sodium-coupled transporters
Krishnamurthy, H., Piscitelli, C. L., & Gouaux, E. (2009) · Nature · doi:10.1038/nature08143 · Cited by 324
From Isocyanides via Four‐Component Condensations to Antibiotic Syntheses
Ugi, I. (1982) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198208101 · Cited by 323
Caspases: Keys in the Ignition of Cell Death
Denault, J.-B., & Salvesen, G. S. (2002) · Chemical Reviews · doi:10.1021/cr010183n · Cited by 309
Genomic-scale prioritization of drug targets: the TDR Targets database
Agüero, F., Al-Lazikani, B., Aslett, M., Berriman, M., Buckner, F. S., Campbell, R. K., Carmona, S., Carruthers, I. M., Chan, A. W. E., Chen, F., et al. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2684 · Cited by 306
Development trends for therapeutic antibody fragments
Nelson, A. L., & Reichert, J. M. (2009) · Nature Biotechnology · doi:10.1038/nbt0409-331 · Cited by 305
Ertl, P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0255782 · Cited by 292
Prolyl peptidases: a serine protease subfamily with high potential for drug discovery
Rosenblum, J. S., & Kozarich, J. W. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00084-x · Cited by 284
Chemotherapy of schistosomiasis: present and future
Caffrey, C. R. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.031 · Cited by 277
Mutations in the kinesin-like protein Eg5 disrupting localization to the mitotic spindle
Sawin, K. E., & Mitchison, T. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4289 · Cited by 271
Ugi, I. (1962) · Angewandte Chemie · doi:10.1002/ange.19620740103 · Cited by 266
Popowicz, G. M., Czarna, A., Wolf, S., Wang, K., Wang, W., Dömling, A., & Holak, T. A. (2010) · Cell Cycle · doi:10.4161/cc.9.6.10956 · Cited by 230
Self-citationSmall-Molecule Screen Identifies Inhibitors of a Human Intestinal Calcium-Activated Chloride Channel
De La Fuente, R., Namkung, W., Mills, A., & Verkman, A. S. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043208 · Cited by 224
Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure
Tyndall, J. D. A., Pfeiffer, B., Abbenante, G., & Fairlie, D. P. (2005) · Chemical Reviews · doi:10.1021/cr040689g · Cited by 222
Magano, J. (2009) · Chemical Reviews · doi:10.1021/cr800449m · Cited by 216
Cavalli, A., & Bolognesi, M. L. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9004835 · Cited by 211
Small Molecule Modulators of Endogenous and Co-chaperone-stimulated Hsp70 ATPase Activity
Fewell, S. W., Smith, C. M., Lyon, M. A., Dumitrescu, T. P., Wipf, P., Day, B. W., & Brodsky, J. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404857200 · Cited by 211
Kemnitzer, W., Drewe, J., Jiang, S., Zhang, H., Crogan-Grundy, C., Labreque, D., Bubenick, M., Attardo, G., Denis, R., Lamothe, S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7010657 · Cited by 206
Inhibition of a Mitotic Motor Protein: Where, How, and Conformational Consequences
Yan, Y., Sardana, V., Xu, B., Homnick, C., Halczenko, W., Buser, C. A., Schaber, M., Hartman, G. D., Huber, H. E., & Kuo, L. C. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.074 · Cited by 205
Aliskiren: the first renin inhibitor for clinical treatment
Jensen, C., Herold, P., & Brunner, H. R. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2550 · Cited by 205
Optimization of the Biological Activity of Combinatorial Compound Libraries by a Genetic Algorithm
Weber, L., Wallbaum, S., Broger, C., & Gubernator, K. (1995) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199522801 · Cited by 196
Indole Alkaloids from the Tunicate Aplidium meridianum
Franco, L. H., Joffé, E. B. D. K., Puricelli, L., Tatian, M., Seldes, A. M., & Palermo, J. A. (1998) · Journal of Natural Products · doi:10.1021/np970493u · Cited by 194
Diketopiperazines in peptide and combinatorial chemistry
Fischer, P. M. (2003) · Journal of Peptide Science · doi:10.1002/psc.446 · Cited by 192
The Gewald multicomponent reaction
Huang, Y., & Dömling, A. (2011) · Molecular Diversity · doi:10.1007/s11030-010-9229-6 · Cited by 176
Self-citationKinomics—structural biology and chemogenomics of kinase inhibitors and targets
Vieth, M., Higgs, R. E., Robertson, D. H., Shapiro, M., Gragg, E. A., & Hemmerle, H. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.028 · Cited by 175
Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?
Wade, M., & Wahl, G. M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0423 · Cited by 170
Ueber einen neuen aus Aldehyd ‐ Ammoniak und Blausäure entstehenden Körper
Strecker, A. (1854) · Justus Liebigs Annalen der Chemie · doi:10.1002/jlac.18540910309 · Cited by 168
Parks, D. J., LaFrance, L. V., Calvo, R. R., Milkiewicz, K. L., Gupta, V., Lattanze, J., Ramachandren, K., Carver, T. E., Petrella, E. C., Cummings, M. D., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.11.009 · Cited by 167
Wanted: new multicomponent reactions for generating libraries of polycyclic natural products
Ulaczyk-Lesanko, A., & Hall, D. G. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.04.003 · Cited by 166
Targeting protein–protein interactions for cancer therapy
Fry, D. C., & Vassilev, L. T. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0705-x · Cited by 159
Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective
Zhao, H. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.12.003 · Cited by 159
The Generation of Dihydropyrimidine Libraries Utilizing Biginelli Multicomponent Chemistry
Kappe, C. O. (2003) · QSAR & Combinatorial Science · doi:10.1002/qsar.200320001 · Cited by 158
Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors
Dai, Y., Guo, Y. P., Frey, R. R., Ji, Z., Curtin, M. L., Ahmed, A. A., Albert, D. H., Arnold, L. D., Arries, S. S., Barlozzari, T., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050458h · Cited by 154
Tong, L. (2002) · Chemical Reviews · doi:10.1021/cr010184f · Cited by 154
Multicomponent Synthesis of 2-Imidazolines
Bon, R. S., van Vliet, B., Sprenkels, N. E., Schmitz, R. F., de Kanter, F. J. J., Stevens, C. V., Swart, M., Bickelhaupt, F. M., Groen, M. B., & Orrù, R. V. A. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo050132g · Cited by 152
Catalytic Three‐Component Ugi Reaction
Pan, S. C., & List, B. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800494 · Cited by 147
Pedemonte, N., Sonawane, N. D., Taddei, A., Hu, J., Zegarra‐Moran, O., Suen, Y. F., Robins, L. I., Dicus, C. W., Willenbring, D., Nantz, M. H., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.010959 · Cited by 146
Crystal Structure Analysis of Deamino-Oxytocin: Conformational Flexibility and Receptor Binding
Wood, S., Tickle, I. J., Treharne, A., Pitts, J. E., Mascarenhas, Y. P., Li, J. Y., Husain, J., Cooper, S. J., Blundell, T. L., Hruby, V. J., et al. (1986) · Science · doi:10.1126/science.3008332 · Cited by 137
Czarna, A., Beck, B., Srivastava, S., Popowicz, G. M., Wolf, S., Huang, Y., Biśta, M., Holak, T. A., & Dömling, A. S. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201001343 · Cited by 137
Self-citationHardcastle, I. R., Arris, C. E., Bentley, J., Boyle, F. T., Chen, Y., Curtin, N. J., Endicott, J., Gibson, A. E., Golding, B. T., Griffin, R. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0311442 · Cited by 130
The structural and functional diversity of Hsp70 proteins from Plasmodium falciparum
Shonhai, A., Boshoff, A., & Blatch, G. L. (2007) · Protein Science · doi:10.1110/ps.072918107 · Cited by 130
Oefner, C., Binggeli, A., Breu, V., Bur, D., Clozel, J.-P., D'Arcy, A., Dorn, A., Fischli, W., Grüninger, F., Güller, R., et al. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)89004-8 · Cited by 127
Design and Synthesis of Cyclic RGD Pentapeptoids by Consecutive Ugi Reactions
Vercillo, O. E., Andrade, C. K. Z., & Wessjohann, L. A. (2007) · Organic Letters · doi:10.1021/ol702521g · Cited by 124
Reynès, C., Host, H., Camproux, A., Laconde, G., Leroux, F., Mazars, A., Deprez, B. P., Fåhræus, R., Villoutreix, B. O., & Spérandio, O. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000695 · Cited by 124
Bettayeb, K., Tirado, Ò. M., Marionneau‐Lambot, S., Ferandin, Y., Lozach, O., Morris, J. C., Mateo‐Lozano, S., Drueckes, P., Schächtele, C., Kubbutat, M. H. G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1826 · Cited by 121
Wolfe, M. S. (2009) · Chemical Reviews · doi:10.1021/cr8004197 · Cited by 120
Novel animal-health drug targets from ligand-gated chloride channels
Raymond, V., & Sattelle, D. B. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd821 · Cited by 117
Sakanari, J. A., Staunton, C. E., Eakin, A. E., Craik, C. S., & McKerrow, J. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4863 · Cited by 116
Short and Diverse Route Toward Complex Natural Product-Like Macrocycles
Beck, B., Larbig, G., Mejat, B., Magnin‐Lachaux, M., Picard, A., Herdtweck, E., & Dömling, A. S. S. (2003) · Organic Letters · doi:10.1021/ol034077e · Cited by 112
Self-citationX-ray structure breakthroughs in the GPCR transmembrane region
Topiol, S., & Sabio, M. L. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.02.012 · Cited by 106
Heckmann, D., Meyer, A., Marinelli, L., Zahn, G., Stragies, R., & Kessler, H. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700008 · Cited by 102
Africa's 32 Cents Solution for HIV/AIDS
Hotez, P. J., Fenwick, A., & Kjetland, E. F. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000430 · Cited by 101
Odell, L. R., Nilsson, M. T., Gising, J., Lagerlund, O., Muthas, D., Nordqvist, A., Karlén, A., & Larhed, M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.045 · Cited by 94
Hansen, M., Nours, J. L., Johansson, E., Antal, T. L., Ullrich, A., Löffler, M., & Larsen, S. (2004) · Protein Science · doi:10.1110/ps.03533004 · Cited by 94
A Resource-Efficient and Highly Flexible Procedure for a Three-Component Synthesis of 2-Imidazolines
Elders, N., Schmitz, R. F., de Kanter, F. J. J., Ruijter, E., Groen, M. B., & Orrù, R. V. A. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo070840x · Cited by 93
The discovery of GSK221149A: A potent and selective oxytocin antagonist
Liddle, J., Allen, M. J., Borthwick, A. D., Brooks, D. P., Davies, D. E., Edwards, R. M., Exall, A. M., Hamlett, C. C. F., Irving, W. R., Mason, A. M., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.008 · Cited by 91
A genomic perspective on human proteases as drug targets
Southan, C. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01793-7 · Cited by 87
Discovery of the first selective inhibitor of excitatory amino acid transporter subtype 1.
Jensen, A. A., Erichsen, M. N., Nielsen, C., Stensbøl, T. B., Kehler, J., & Bunch, L. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8013458 · Cited by 86
Enantioselective Synthesis of SNAP-7941: Chiral Dihydropyrimidone Inhibitor of MCH1-R
Goss, J. M., & Schaus, S. E. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo801463j · Cited by 85
Oefner, C., D'Arcy, A., Sweeney, A. M., et al. (2003) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444903010059 · Cited by 83
Richter, H. G., Benson, G. M., Bleicher, K., Blum, D., Chaput, E., Clemann, N., Feng, S., Gardès, C., Grether, U., HARTMAN, P. G., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.123 · Cited by 79
Structure-based development of target-specific compound libraries
Orry, A. J. W., Abagyan, R. A., & Cavasotto, C. N. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03717-7 · Cited by 79
Parks, D. J., LaFrance, L. V., Calvo, R. R., Milkiewicz, K. L., Marugán, J., Raboisson, P., Schubert, C., Koblish, H. K., Zhao, S., Franks, C. F., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.055 · Cited by 77
Zographos, S. E., Oikonomakos, N. G., Tsitsanou, K. E., Leonidas, D. D., Chrysina, E. D., Skamnaki, V. T., Bischoff, H., Goldmann, S., Watson, K. A., & Johnson, L. N. (1997) · Structure · doi:10.1016/s0969-2126(97)00292-x · Cited by 77
Musonda, C. C., Taylor, D., Lehman, J., Gut, J., Rosenthal, P. J., & Chibale, K. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.05.063 · Cited by 76
Ishihara, A., Kanatani, A., Mashiko, S., Tanaka, T., Hidaka, M., Gomori, A., Iwaasa, H., Murai, N., Egashira, S., Murai, T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510320103 · Cited by 76
Chipeleme, A., Gut, J., Rosenthal, P. J., & Chibale, K. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.055 · Cited by 76
NMR structure of a complex between MDM2 and a small molecule inhibitor
Fry, D. C., Emerson, S. D., Palme, S., Vu, B. T., Liu, C., & Podlaski, F. (2004) · Journal of Biomolecular NMR · doi:10.1023/b:jnmr.0000048856.84603.9b · Cited by 75
Orexin Receptor Antagonists: A New Concept In CNS Disorders?
Gatfield, J., Roch, C., Jenck, F., & Boss, C. (2010) · ChemMedChem · doi:10.1002/cmdc.201000132 · Cited by 73
Biomedical Application of Orexin/Hypocretin Receptor Ligands in Neuroscience
Boss, C., Roch, C., & Jenck, F. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801296d · Cited by 72
Structure of Human Eg5 in Complex with a New Monastrol-based Inhibitor Bound in the R Configuration
Garcia-Saez, I., DeBonis, S., Lopez, R., Trucco, F., Rousseau, B., Thuéry, P., & Kozielski, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608883200 · Cited by 72
Praziquantel and Schistosomiasis
Dömling, A. S. S., & Khoury, K. (2010) · ChemMedChem · doi:10.1002/cmdc.201000202 · Cited by 70
Self-citationWyatt, P. G., Allen, M. J., Borthwick, A. D., Davies, D. E., Exall, A. M., Hatley, R. J. D., Irving, W. R., Livermore, D. G., Miller, N. D., Nerozzi, F., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.045 · Cited by 68
Kalinski, C., Umkehrer, M., Weber, L., Kolb, J., Burdack, C., & Roß, G. (2010) · Molecular Diversity · doi:10.1007/s11030-010-9225-x · Cited by 68
Kolb, P., Kipouros, C. B., Danzhi Huang, A., & Caflisch, A. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22028 · Cited by 68
A structural model for monastrol inhibition of dimeric kinesin Eg5
Krzysiak, T. C., Wendt, T. G., Sproul, L. R., Tittmann, P., Gross, H., Gilbert, S. P., & Hoenger, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601108 · Cited by 67
Identification of PDE4B Over 4D subtype-selective inhibitors revealing an unprecedented binding mode
Kranz, M., Wall, M., Evans, B., Miah, A. H., Ballantine, S. P., Delves, C. J., Dombroski, B., Gross, J. W., Schneck, J. L., Villa, J. P., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.03.061 · Cited by 66
1,4‐Thienodiazepine‐2,5‐diones via MCR (I): Synthesis, Virtual Space and p53‐Mdm2 Activity
Huang, Y., Wolf, S., Biśta, M., Meireles, L., Camacho, C. J., Holak, T. A., & Dömling, A. S. S. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.00989.x · Cited by 65
Self-citationSchiemann, K., Finsinger, D., Zenke, F. T., Amendt, C., Knöchel, T., Bruge, D., Buchstaller, H., Emde, U., Stähle, W. K., & Anzali, S. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.110 · Cited by 64
Progress and problems in the exploration of therapeutic targets
Zheng, C., Han, L., Yap, C. W., Xie, B., & Chen, Y. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.03.012 · Cited by 62
Discovery of protein–protein binding disruptors using multi-component condensations small molecules
Bedjeguelal, K., Bienaymé, H., Dumoulin, A., Poigny, S., Schmitt, P., & Tam, E. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.05.014 · Cited by 62
Richter, H. G., Benson, G. M., Blum, D., Chaput, E., Feng, S., Gardès, C., Grether, U., HARTMAN, P. G., Kuhn, B., Martin, R. E., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.039 · Cited by 61
Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity
Leonard, K. A., Marugán, J., Raboisson, P., Calvo, R. R., Gushue, J. M., Koblish, H. K., Lattanze, J., Zhao, S., Cummings, M. D., Player, M. R., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.04.009 · Cited by 61
Barrow, J. C., Stauffer, S. R., Rittle, K. E., Ngo, P. L., Yang, Z.-Q., Selnick, H. G., Graham, S. L., Munshi, S. K., McGaughey, G. B., Holloway, M. K., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800914n · Cited by 61
Sato, N., Jitsuoka, M., Shibata, T., Hirohashi, T., Nonoshita, K., Moriya, M., Haga, Y., Sakuraba, A., Ando, M., Ohe, T., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8003587 · Cited by 59
The Biochemistry and Molecular Biology of the Glucose-6-Phosphatase System 1
Foster, J. D., & Nordlie, R. C. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700807 · Cited by 58
Melchiorre, C., Bolognesi, M. L., Minarini, A., Rosini, M., & Tumiatti, V. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100293f · Cited by 57
Lee, A. Y., Hagihara, M., Karmacharya, R., Albers, M. W., Schreiber, S. L., & Clardy, J. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00079a065 · Cited by 57
Borthwick, A. D., Davies, D. E., Exall, A. M., Livermore, D. G., Sollis, S. L., Nerozzi, F., Allen, M. J., Perren, M. J., Shabbir, S., Woollard, P. M., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050557v · Cited by 55
Isoquinolin‐1‐one Inhibitors of the MDM2–p53 Interaction
Rothweiler, U., Czarna, A., Krajewski, M., Ciombor, J., Kalinski, C., Khazak, V., Roß, G., Skobeleva, N., Weber, L., & Holak, T. A. (2008) · ChemMedChem · doi:10.1002/cmdc.200800025 · Cited by 55
Tempest, P. A. (2005) · PubMed · Cited by 55
Refino, C., Burcklen, L., Himber, J., Roux, S., & Kirchhofer, D. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615608 · Cited by 52
Humphries, P. S., Benbow, J. W., Bonin, P. D., Boyer, D. D., Doran, S. D., Frisbie, R. K., Piotrowski, D. W., Balan, G., Bechle, B. M., Conn, E. L., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.082 · Cited by 51
Heal, W. P., Thompson, M. J., Mutter, R., Cope, H., Louth, J. C., & Chen, B. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0612719 · Cited by 45
Wright, C. M., Seguin, S. P., Fewell, S. W., Zhang, H., Ishwad, C., Vats, A. N., Lingwood, C. A., Wipf, P., Fanning, E., Pipas, J. M., et al. (2009) · Virus Research · doi:10.1016/j.virusres.2008.12.018 · Cited by 44
Dihydropyrazolopyrimidines containing benzimidazoles as KV1.5 potassium channel antagonists
Lloyd, J., Finlay, H. J., Atwal, K. S., Kover, A., PROL, J. J., Yan, L., Bhandaru, R., Vaccaro, W. D., Huynh, T., Huang, C., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.083 · Cited by 43
Short and Novel Stereospecific Synthesis of Trisubstituted 2,5-Diketopiperazines
Sollis, S. L. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo0501137 · Cited by 43
Mashiko, S., Ishihara, A., Iwaasa, H., Sano, H., Itô, J., Gomori, A., Oda, Z., Moriya, R., Matsushita, H., Jitsuoka, M., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.029991 · Cited by 41
Krajewski, M., Rothweiler, U., D’Silva, L., Majumdar, S., Klein, C., & Holak, T. A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070365v · Cited by 40
Grolla, A. A., Podestà, V., Chini, M. G., Micco, S. D., Vallario, A., Genazzani, A. A., Canonico, P. L., Bifulco, G., Tron, G. C., Sorba, G., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801529c · Cited by 38
Novel cell-penetrating α-keto-amide calpain inhibitors as potential treatment for muscular dystrophy
Lescop, C., Herzner, H., Siendt, H., Bolliger, R., Henneböhle, M., Weyermann, P., Briguet, A., Courdier-Fruh, I., Erb, M., Foster, M., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.064 · Cited by 37
Norstatines from Aldehydes by Sequential Organocatalytic α‐Amination and Passerini Reaction
Umbreen, S., Brockhaus, M., Ehrenberg, H., & Schmidt, B. (2006) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200600502 · Cited by 35
Enantiomerically pure 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists
Marugán, J., Leonard, K. A., Raboisson, P., Gushue, J. M., Calvo, R. R., Koblish, H. K., Lattanze, J., Zhao, S., Cummings, M. D., Player, M. R., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.067 · Cited by 35
Scaffold‐Hopping Cascade Yields Potent Inhibitors of 5‐Lipoxygenase
Hofmann, B., Franke, L., Proschak, E., Tanrikulu, Y., Schneider, P., Steinhilber, D., & Schneider, G. (2008) · ChemMedChem · doi:10.1002/cmdc.200800153 · Cited by 34
Velázquez, F., Venkatraman, S., Wu, W., et al. (2007) · Organic Letters · doi:10.1021/ol0711265 · Cited by 32
Rapid and Efficient Hydrophilicity Tuning of p53/mdm2 Antagonists
Srivastava, S., Beck, B., Wang, W., Czarna, A., Holak, T. A., & Dömling, A. S. S. (2009) · Journal of Combinatorial Chemistry · doi:10.1021/cc9000218 · Cited by 32
Self-citationMonfardini, I., Huang, J., Beck, B., Cellitti, J. F., Pellecchia, M., & Dömling, A. S. S. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101341m · Cited by 30
Self-citationA Multicomponent Reaction Towards N‐(Cyanomethyl)amides
Elders, N., Ruijter, E., de Kanter, F. J. J., Janssen, E., Lutz, M., Spek, A. L., & Orrù, R. V. A. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200900785 · Cited by 27
Discovery of small molecule human C5a receptor antagonists
Sanganee, H. J., Baxter, A., Barber, S., Brown, A., Grice, D., Hunt, F., King, S. J., Laughton, D. L., Pairaudeau, G., Thong, B., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.104 · Cited by 27
McCafferty, G., Pullen, M., Wu, C. W., Edwards, R., Allen, M., Woollard, P., Borthwick, A. D., Liddle, J., Hickey, D., Brooks, D. P., et al. (2007) · American Journal of Physiology. Regulatory Integrative and Comparative Physiology · doi:10.1152/ajpregu.00057.2007 · Cited by 26
When analoging is not enough: scaffold discovery in medicinal chemistry
Zhao, H., & Akritopoulou‐Zanze, I. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903584874 · Cited by 25
Knowledge-Based Virtual Screening: Application to the MDM4/p53 Protein–Protein Interaction
Jacoby, E., Boettcher, A., Mayr, L. M., Brown, N., Jenkins, J. L., Kallen, J. A., Engeloch, C., Schopfer, U., Furet, P., Masuya, K., et al. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-274-2_7 · Cited by 20
Topography-biased compound library design: the shape of things to come?
Akritopoulou‐Zanze, I., Metz, J. T., & Djurić, S. W. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.08.017 · Cited by 19
Dow, R. L., Hadcock, J. R., Scott, D. O., Schneider, S. R., Paight, E. S., Iredale, P. A., Carpino, P. A., Griffith, D. A., Hammond, M., & DaSilva-Jardine, P. A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.130 · Cited by 11
Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonists
Hammond, M., Patterson, J. R., Manns, S., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.146 · Cited by 10
The art and practice of structure-based drug design: A molecular modeling perspective
(1996) · doi:10.1002/(sici)1098-1128(199601)16:1<3::aid-med1>3.0.co;2-6
Cited by
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
Gawande, M. B., Goswami, A., Felpin, F.-X., Asefa, T., Huang, X., Silva, R., Zou, X., Zboril, R., & Varma, R. S. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00482 · Cited by 2,934
Isatins As Privileged Molecules in Design and Synthesis of Spiro-Fused Cyclic Frameworks
Singh, G. S., & Desta, Z. Y. (2012) · Chemical Reviews · doi:10.1021/cr300135y · Cited by 1,601
Multicomponent reactions: advanced tools for sustainable organic synthesis
Cioc, R. C., Ruijter, E., & Orru, R. V. A. (2014) · Green Chem. · doi:10.1039/c4gc00013g · Cited by 1,339
Nonclassical Routes for Amide Bond Formation
de Figueiredo, R. M., Suppo, J.-S., & Campagne, J.-M. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00237 · Cited by 978
Gawande, M. B., Shelke, S. N., Zboril, R., & Varma, R. S. (2014) · Accounts of Chemical Research · doi:10.1021/ar400309b · Cited by 774
Metadata
- Authors
- Dömling, A., Wang, W., & Wang, K.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-03-22
- Volume
- 112
- Issue
- 6
- Pages
- 3083-3135
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2114809965
- Cited by
- 2,547
- References
- 170
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.